Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Francioli

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
AIDS (London, England)|September 16, 2011
Fatal and nonfatal AIDS and non-AIDS events in HIV-1-positive individuals with high CD4 cell counts according to viral load strataJoanne Reekie, Jose M Gatell, Israel Yust, et al.
Spine|August 19, 2008
Cefuroxime prophylaxis is effective in noninstrumented spine surgery: a double-blind, placebo-controlled studyChristiane Petignat, Patrick Francioli, Stephan Harbarth, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 21, 2004
A randomized clinical trial to compare fleroxacin-rifampicin with flucloxacillin or vancomycin for the treatment of staphylococcal infectionJacques Schrenzel, Stephan Harbarth, Gérard Schockmel, et al.
The Journal of Experimental Medicine|May 18, 2005
Fibrinogen and fibronectin binding cooperate for valve infection and invasion in Staphylococcus aureus experimental endocarditisYok-Ai Que, Jacques-Antoine Haefliger, Lionel Piroth, et al.
AIDS (London, England)|February 16, 2007
Polymorphisms in Toll-like receptor 9 influence the clinical course of HIV-1 infectionPierre-Yves Bochud, Martin Hersberger, Patrick Taffé, et al.
AIDS (London, England)|August 28, 2007
Short-term clinical disease progression in HIV-1-positive patients taking combination antiretroviral therapy: the EuroSIDA risk-scoreAmanda Mocroft, Bruno Ledergerber, Kai Zilmer, et al.
Journal of Hepatology|August 12, 2009
Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis CPierre-Yves Bochud, Tao Cai, Kathrin Overbeck, et al.
Emerging Infectious Diseases|October 27, 2004
Molecular evidence of interhuman transmission of Pneumocystis pneumonia among renal transplant recipients hospitalized with HIV-infected patientsMeja Rabodonirina, Philippe Vanhems, Sandrine Couray-Targe, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 21, 2009
Long-term trends of HIV type 1 drug resistance prevalence among antiretroviral treatment-experienced patients in SwitzerlandViktor von Wyl, Sabine Yerly, Philippe Bürgisser, et al.
AIDS (London, England)|September 28, 2002
Intermittent and sustained low-level HIV viral rebound in patients receiving potent antiretroviral therapyGilbert Greub, Alessandro Cozzi-Lepri, Bruno Ledergerber, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
AIDS (London, England)|September 16, 2011
Fatal and nonfatal AIDS and non-AIDS events in HIV-1-positive individuals with high CD4 cell counts according to viral load strataJoanne Reekie, Jose M Gatell, Israel Yust, et al.
Spine|August 19, 2008
Cefuroxime prophylaxis is effective in noninstrumented spine surgery: a double-blind, placebo-controlled studyChristiane Petignat, Patrick Francioli, Stephan Harbarth, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 21, 2004
A randomized clinical trial to compare fleroxacin-rifampicin with flucloxacillin or vancomycin for the treatment of staphylococcal infectionJacques Schrenzel, Stephan Harbarth, Gérard Schockmel, et al.
The Journal of Experimental Medicine|May 18, 2005
Fibrinogen and fibronectin binding cooperate for valve infection and invasion in Staphylococcus aureus experimental endocarditisYok-Ai Que, Jacques-Antoine Haefliger, Lionel Piroth, et al.
AIDS (London, England)|February 16, 2007
Polymorphisms in Toll-like receptor 9 influence the clinical course of HIV-1 infectionPierre-Yves Bochud, Martin Hersberger, Patrick Taffé, et al.
AIDS (London, England)|August 28, 2007
Short-term clinical disease progression in HIV-1-positive patients taking combination antiretroviral therapy: the EuroSIDA risk-scoreAmanda Mocroft, Bruno Ledergerber, Kai Zilmer, et al.
Journal of Hepatology|August 12, 2009
Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis CPierre-Yves Bochud, Tao Cai, Kathrin Overbeck, et al.
Emerging Infectious Diseases|October 27, 2004
Molecular evidence of interhuman transmission of Pneumocystis pneumonia among renal transplant recipients hospitalized with HIV-infected patientsMeja Rabodonirina, Philippe Vanhems, Sandrine Couray-Targe, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 21, 2009
Long-term trends of HIV type 1 drug resistance prevalence among antiretroviral treatment-experienced patients in SwitzerlandViktor von Wyl, Sabine Yerly, Philippe Bürgisser, et al.
AIDS (London, England)|September 28, 2002
Intermittent and sustained low-level HIV viral rebound in patients receiving potent antiretroviral therapyGilbert Greub, Alessandro Cozzi-Lepri, Bruno Ledergerber, et al.
Pageof 5